Lung tumours: Difference between revisions
Jump to navigation
Jump to search
| Line 234: | Line 234: | ||
*CD99 +ve (23/23 cases<ref name=pmid15460417/>). | *CD99 +ve (23/23 cases<ref name=pmid15460417/>). | ||
*SMA -ve/+ve (7 +ve/23 cases<ref name=pmid15460417/>). | *SMA -ve/+ve (7 +ve/23 cases<ref name=pmid15460417/>). | ||
Suggested stain:{{fact}} | |||
*CD34, CD99, BCL2, S-100, Ki-67. | |||
===Sign out=== | ===Sign out=== | ||